OLD Category: Oncology

Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer

• Ham I.-H. et. al.,

A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer

• Karlsson A. et. al.,

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

• Formisano L. et. al.,

Critical role of kinase activity of hematopoietic progenitor kinase 1 in anti-tumor immune surveillance

• Liu J. et. al.,

Investigation into the Molecular Mechanisms underlying the Anti-proliferative and Anti-tumorigenesis activities of Diosmetin against HCT-116 Human Colorectal Cancer

• Koosha S. et. al.,

Molecular subtyping of cancer: current status and moving toward clinical applications

• Zhao L et al.,

Inhibition of miR-328–3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer

• Srivastava AK et al.,

Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer

• Puca L. et. al.,

Pan-TAM tyrosine kinase inhibitor BMS-777607 enhances anti-PD-1 mAb efficacy in a murine model of triple-negative breast cancer

• Kasikara C. et. al.,

Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma

• Kieran MW et al.,

Multiplatform Biomarker Identification using a Data-driven Approach Enables Single-sample Classification

• Zhang L et al.,

Elucidating the mechanism of action of domatinostat (4SC-202) in cutaneous T cell lymphoma cells

• Wobser M. et. al.,